Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 43
Filter
2.
Malays J Pathol ; 45(1): 111-122, 2023 Apr.
Article in English | MEDLINE | ID: mdl-37119251

ABSTRACT

INTRODUCTION: Desmoid fibromatosis is a multifactorial disorder classified as a category of intermediate, locally aggressive behaviour, which might be associated with CTNNB1 or APC mutations, trauma, surgery, or pregnancy. CASE REPORTS: We present two cases of postoperative intra-abdominal desmoid fibromatosis. The first case occurred 14 months after the resection of a retroperitoneal gastrointestinal stromal tumour. The second case was located in the mesentery, as evidenced on an 18-month followup after a laparoscopy-assisted anterior resection for adenocarcinoma at the rectosigmoid junction. Under the clinical diagnosis of recurrence, tissue excisions were conducted. Microscopically, the tissue was composed of bland spindle cells without cytological atypia, admixed with collagen bundles. Both tumours exhibited nuclear expression of ß-catenin on immunohistochemical staining, which is a desirable criterion for desmoid fibromatosis. DISCUSSION: Although positron emission tomography aids the diagnosis of recurrence, the radiological features of desmoid fibromatosis in computed tomography or magnetic resonance images are nonspecific and preoperative diagnosis of desmoid fibromatosis is difficult. The histological diagnosis of desmoid fibromatosis is difficult, especially when the specimen is small. The histological differential diagnosis of desmoid fibromatosis includes other myofibroblastic or fibroblastic tumours or lesions. Additional studies, such as ß-catenin immunohistochemistry or CTNNB1 mutation analysis, can enable accurate diagnosis of desmoid fibromatosis. A correct diagnosis is essential, because the current therapeutic strategy is a "waitand- watch" approach, which is significantly different from those of the other locally aggressive, intermediate soft tissue neoplasms. We have summarised the clinicopathological, histological and immunohistochemical features of the post-operative desmoid fibromatosis.


Subject(s)
Fibromatosis, Aggressive , Humans , Fibromatosis, Aggressive/diagnosis , Fibromatosis, Aggressive/surgery , Fibromatosis, Aggressive/genetics , beta Catenin/genetics , beta Catenin/analysis , Neoplasm Recurrence, Local/diagnosis , Neoplasm Recurrence, Local/pathology , Immunohistochemistry , Diagnosis, Differential
3.
QJM ; 111(6): 389-397, 2018 Jun 01.
Article in English | MEDLINE | ID: mdl-29554373

ABSTRACT

BACKGROUND: Although asymptomatic microscopic hematuria (MH) is a common finding in clinical practice, its long-term outcome remains unknown. AIM: This study evaluated the clinical implication of MH in the general population using a large-scale long-term longitudinal cohort database. METHODS: This study included 8719 participants from the Korean Genome and Epidemiology Study between 2001 and 2014. MH was defined as ≥5 red blood cells per high-power field in random urinalysis without evidence of pyuria. The primary study outcome measure was incident chronic kidney disease (CKD), defined as estimated glomerular filtration rate <60 ml min-1⋅1.73⋅m-2. RESULTS: During a median follow-up of 11.7 years, CKD occurred in 677 (7.8%) subjects. In Cox regression after adjustment for multiple confounders, subjects with MH had a significantly higher risk of incident CKD than those without [hazard ratio (HR) 1.45, 95% confidence interval (CI) 1.12-1.87; P = 0.005]. Isolated MH without proteinuria was also a risk factor of incident CKD (HR 1.37, 95% CI 1.04-1.79; P = 0.023) and the risk was further increased in MH with concomitant proteinuria (HR 5.41, 95% CI 2.54-11.49; P < 0.001). In propensity score matching analysis after excluding subjects with proteinuria, multi-variable stratified Cox regression analysis revealed that subjects with isolated MH had a significantly higher risk of incident CKD than those without (HR 1.83, 95% CI 1.14-2.94; P = 0.012). CONCLUSION: The presence of MH is associated with an increased risk of incident CKD in the general population. Therefore, attentive follow-up is warranted in persons with MH for early detection of CKD.


Subject(s)
Hematuria/complications , Hematuria/epidemiology , Renal Insufficiency, Chronic/complications , Renal Insufficiency, Chronic/epidemiology , Adult , Aged , Disease Progression , Female , Glomerular Filtration Rate , Humans , Incidence , Korea/epidemiology , Male , Middle Aged , Multivariate Analysis , Propensity Score , Proportional Hazards Models , Prospective Studies , Proteinuria/complications , Risk Factors , Urinalysis
4.
Clin Exp Dermatol ; 39(1): 25-9, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24341477

ABSTRACT

BACKGROUND: Androgenetic alopecia (AGA) is the most common type of hair loss, and is characterized by the transformation of terminal scalp hair into vellus hair. The epidemiology of AGA is not fully understood. A strong genetic basis has long been identified, although little is known of its nongenetic causes. AIM: To evaluate the association of AGA with a number of environmental factors, including smoking, drinking and sleeping habit. METHODS: In total, 3114 Korean individuals with AGA who attended any one of 17 dermatology clinics in 6 cities in South Korea between March 2011 and February 2012 were enrolled in the study. Epidemiologic a data were collected using a standard questionnaire. RESULTS: No association was seen between eating or sleeping habits and severity of hair loss. However, drinking and smoking were associated with the severity of AGA in male patients. We also found that patients of both genders with a family history had more advanced types of hair loss, and the age of onset of AGA in male patients with a family history was earlier than that in male patients without a family history. CONCLUSIONS: Although the evidence for an environmental influence on AGA remains very weak, we did find an association between hair loss severity and certain environmental factors, such as smoking and drinking. Family history with more severe hair loss and an earlier age of onset.


Subject(s)
Alopecia/epidemiology , Adult , Age Distribution , Age of Onset , Alcohol Drinking/adverse effects , Alopecia/etiology , Alopecia/physiopathology , Female , Humans , Life Style , Male , Prevalence , Republic of Korea/epidemiology , Risk Factors , Sex Distribution , Sleep/physiology , Smoking/adverse effects
5.
Andrologia ; 46(9): 1032-40, 2014.
Article in English | MEDLINE | ID: mdl-24188423

ABSTRACT

This study investigated the protective effects of melatonin (MT) against gentamicin (GM)-induced testicular toxicity and oxidative damage in rats. GM (100 mg kg(-1) ) was injected intraperitoneally (i.p.) to rats for 6 days. MT (15 mg kg(-1) ) was administered i.p. to rats for 6 days at 1 hr after the GM treatment. GM caused a decrease in prostate and seminal vesicle weights, sperm count and sperm motility. Histopathological examination showed various morphological alterations in the testis, characterised by degeneration of spermatogonia/spermatocytes, decrease in the number of early spermatogenic cells and vacuolisation. In addition, an increased malondialdehyde concentration and decreased glutathione content and glutathione reductase, catalase and glutathione-S-transferase activities were found in the testis. In contrast, MT treatment significantly attenuated the testicular toxicity of GM, including decreased reproductive organ weights, sperm count, and sperm motility and increased histopathological alterations. MT also had an antioxidant benefit by decreasing the lipid peroxidative product malondialdehyde and increasing the level of the antioxidant glutathione and the activities of antioxidant enzymes in the testis. These results indicate that MT prevents testicular toxicity induced by GM in rats, presumably due to its potent antioxidant activity, and its ability to inhibit lipid peroxidation, and restore antioxidant enzyme activity.


Subject(s)
Anti-Bacterial Agents/toxicity , Antioxidants/pharmacology , Gentamicins/antagonists & inhibitors , Gentamicins/toxicity , Melatonin/pharmacology , Testis/drug effects , Animals , Antioxidants/metabolism , Glutathione/metabolism , Lipid Peroxidation/drug effects , Male , Malondialdehyde/metabolism , Oxidative Stress/drug effects , Rats , Rats, Sprague-Dawley , Sperm Count , Sperm Motility/drug effects , Testis/metabolism , Testis/pathology
6.
Ann Oncol ; 24(12): 3089-94, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24050953

ABSTRACT

BACKGROUND: This phase II study investigated the efficacy and safety of everolimus, an inhibitor of mammalian target of rapamycin (mTOR), in locally advanced or metastatic thyroid cancer. PATIENTS AND METHODS: Patients with thyroid cancer of any histology that was resistant or not appropriate for (131)I received everolimus 10 mg daily orally until unacceptable toxicity or disease progression. The primary end point was disease control rate [partial response (PR) + stable response ≥12 weeks]. Secondary end points included response rates, clinical benefit (PD + durable stable disease (SD)], progression-free survival (PFS), overall survival, duration of response, and safety. RESULTS: Thirty-eight of 40 enrolled patients were evaluable for efficacy. The disease control rate was 81% and two (5%) patients achieved objective response; their duration of response was 21+ and 24+ weeks. Stable disease (SD) and progressive disease was reported in 76% and 17% of patients, respectively. Seventeen (45%) patients showed durable SD (≥24 weeks) and clinical benefit was reported in 19 (50%) patients. Median PFS was 47 weeks [95% confidence interval (CI) 14.9-78.5]. Calcitonin, CEA, and thyroglobulin concentrations were ≥50% lower than baseline in three (30%) and four (44%) patients with medullary thyroid cancer and five (33%) patients with PTC, respectively. The most common treatment-related adverse events were mucositis (84%), anorexia (44%), and aspartate transaminase/alanine transaminase elevation (26%). CONCLUSIONS: Everolimus had a limited activity with low response rate in locally advanced or metastatic thyroid cancer. Reasonable clinical benefit rate and safety profile may warrant further investigation. CLINICALTRIALSGOV NUMBER: NCT01164176.


Subject(s)
Antineoplastic Agents/therapeutic use , Carcinoma, Medullary/drug therapy , Carcinoma, Papillary/drug therapy , Sirolimus/analogs & derivatives , Thyroid Neoplasms/drug therapy , Adult , Aged , Aged, 80 and over , Carcinoma, Medullary/mortality , Carcinoma, Medullary/secondary , Carcinoma, Papillary/mortality , Carcinoma, Papillary/secondary , Disease-Free Survival , Everolimus , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Neoplasm Staging , Sirolimus/therapeutic use , Thyroid Neoplasms/mortality , Thyroid Neoplasms/pathology , Treatment Outcome
7.
Hum Exp Toxicol ; 32(6): 640-6, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23386780

ABSTRACT

Epichlorohydrin (ECH) is an antifertility agent that acts both as an epididymal toxicant and an agent capable of directly affecting sperm motility. This study identified the time course of apoptotic cell death in rat epididymides after ECH treatment. Rats were administrated with a single oral dose of ECH (50 mg/kg). ECH-induced apoptotic changes were evaluated by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay and its related mechanism was confirmed by Western blot analysis and colorimetric assay. The TUNEL assay showed that the number of apoptotic cells increased at 8 h, reached a maximum level at 12 h, and then decreased progressively. The Western blot analysis demonstrated no significant changes in proapoptotic Bcl-2-associated X (Bax) and anti-apoptotic Bcl-2 expression during the time course of the study. However, phospho-p38 mitogen-activated protein kinase (p-p38 MAPK) and phospho-c-Jun amino-terminal kinase (p-JNK) expression increased at 8-24 h. Caspase-3 and caspase-8 activities also increased at 8-48 h and 12-48 h, respectively, in the same manner as p-p38 MAPK and p-JNK expression. These results indicate that ECH induced apoptotic changes in rat epididymides and that the apoptotic cell death may be related more to the MAPK pathway than to the mitochondrial pathway.


Subject(s)
Apoptosis/drug effects , Epichlorohydrin/toxicity , Epididymis/cytology , Epididymis/drug effects , Animals , Caspase 3/genetics , Caspase 3/metabolism , Caspase 8/genetics , Caspase 8/metabolism , Contraceptive Agents, Male/toxicity , Gene Expression Regulation, Enzymologic , Male , Rats , Rats, Sprague-Dawley
8.
Rev Sci Instrum ; 83(6): 063301, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22755616

ABSTRACT

The pointing instability of energetic electron beams generated from a laser-driven accelerator can cause a serious error in measuring the electron spectrum with a magnetic spectrometer. In order to determine a correct electron spectrum, the pointing angle of an electron beam incident on the spectrometer should be exactly defined. Here, we present a method for absolutely calibrating the electron spectrum by monitoring the pointing angle using a scintillating screen installed in front of a permanent dipole magnet. The ambiguous electron energy due to the pointing instability is corrected by the numerical and analytical calculations based on the relativistic equation of electron motion. It is also possible to estimate the energy spread of the electron beam and determine the energy resolution of the spectrometer using the beam divergence angle that is simultaneously measured on the screen. The calibration method with direct measurement of the spatial profile of an incident electron beam has a simple experimental layout and presents the full range of spatial and spectral information of the electron beams with energies of multi-hundred MeV level, despite the limited energy resolution of the simple electron spectrometer.

9.
Phys Rev Lett ; 109(23): 234801, 2012 Dec 07.
Article in English | MEDLINE | ID: mdl-23368211

ABSTRACT

Nanostructured thin plastic foils have been used to enhance the mechanism of laser-driven proton beam acceleration. In particular, the presence of a monolayer of polystyrene nanospheres on the target front side has drastically enhanced the absorption of the incident 100 TW laser beam, leading to a consequent increase in the maximum proton energy and beam charge. The cutoff energy increased by about 60% for the optimal spheres' diameter of 535 nm in comparison to the planar foil. The total number of protons with energies higher than 1 MeV was increased approximately 5 times. To our knowledge this is the first experimental demonstration of such advanced target geometry. Experimental results are interpreted and discussed by means of 2(1/2)-dimensional particle-in-cell simulations.

10.
Clin Genet ; 79(4): 378-84, 2011 Apr.
Article in English | MEDLINE | ID: mdl-20618350

ABSTRACT

The dentin sialophosphoprotein (DSPP) gene encodes the most abundant non-collagenous protein in tooth dentin and DSPP protein is cleaved into several segments including the highly phosphorylated dentin phosphoprotein (DPP). Mutations in the DSPP gene have been solely related to non-syndromic form of hereditary dentin defects. We recruited three Korean families with dentinogenesis imperfecta (DGI) type II and sequenced the exons and exon-intron boundaries of the DSPP gene based on the candidate gene approach. Direct sequencing of PCR products and allele-specific cloning of the highly repetitive exon 5 revealed novel single base pair (bp) deletional mutations (c.2688delT and c.3560delG) introducing hydrophobic amino acids in the hydrophilic repeat domain of the DPP coding region. All affected members of the three families showed exceptionally rapid pulp chambers obliteration, even before tooth eruption. Individuals with the c.3560delG mutation showed only mild, yellowish tooth discoloration, in contrast to the affected individuals from two families with c.2688delT mutation. We believe that these results will help us to understand the molecular pathogenesis of DGI type II as well as the normal process of dentin biomineralization.


Subject(s)
Dentinogenesis Imperfecta/genetics , Extracellular Matrix Proteins/genetics , Frameshift Mutation , Phosphoproteins/genetics , Sialoglycoproteins/genetics , Base Sequence , DNA Mutational Analysis , Dentinogenesis Imperfecta/classification , Dentinogenesis Imperfecta/pathology , Family Health , Female , Humans , Korea , Male , Molecular Sequence Data , Pedigree , Sequence Deletion
11.
J Dent Res ; 89(12): 1378-82, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20938048

ABSTRACT

The proven candidate genes for amelogenesis imperfecta (AI) are AMELX, ENAM, MMP20, KLK4, FAM83H, and WDR72. We performed mutation analyses on seven families with hypomaturation AI. A novel WDR72 dinucleotide deletion mutation (g.57,426_57,427delAT; c.1467_ 1468delAT; p.V491fsX497) was identified in both alleles of probands from Mexico and Turkey. Haplotype analyses showed that the mutations arose independently in the two families. The disease perfectly segregated with the genotype. Only persons with both copies of the mutant allele were affected. Their hypomineralized enamel suffered attrition and orange-brown staining following eruption. Expression of WDR72 fused to green fluorescent protein showed a cytoplasmic localization exclusively and was absent from the nucleus. We conclude that WDR72 is a cytoplasmic protein that is critical for dental enamel formation.


Subject(s)
Amelogenesis Imperfecta/genetics , Cytoplasm/ultrastructure , Proteins/genetics , Sequence Deletion/genetics , Adenine , Alleles , Codon, Nonsense/genetics , Dental Enamel/pathology , Exons/genetics , Genotype , Green Fluorescent Proteins , Haplotypes/genetics , Homozygote , Humans , Introns/genetics , Microscopy, Confocal , Microscopy, Fluorescence , Pedigree , Polymorphism, Single Nucleotide/genetics , Sequence Analysis, DNA , Thymine , Tooth Attrition/genetics , Tooth Discoloration/genetics , Valine/genetics
13.
Acoust Phys ; 55(4-5): 594-601, 2009 Oct 01.
Article in English | MEDLINE | ID: mdl-20160872

ABSTRACT

The article describes the study of targeted chemotherapeutic intervention on solid tumors by means of ultrasound and doxorubicin- or paclitaxel-loaded perfluoropentane nanoemulsions. Nanodroplets of the emulsions accumulated in a tumor by passive targeting. Under the action of a tumor-directed therapeutic ultrasound, the nanodroplets converted into vapor microbubbles. In vivo, the nanodroplets strongly retained the loaded drugs; yet, under ultrasound-mediated vaporization they released the drugs into the tumor tissue, thereby implementing effective targeting into the tumor. The tumors subjected to this treatment regressed effectively; however, after some time they recurred. The recurring tumors were more resistant to the repeated therapy than the primary ones. At present, the causes of of the resistance development and methods for its elimination are unclear and they are under investigation.

14.
Transplant Proc ; 40(10): 3751-4, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19100481

ABSTRACT

The chronic use of immunosuppressive therapy in transplant recipients increases the long-term risk for carcinoma. However, there is insufficient knowledge regarding the incidence and biological behavior of papillary thyroid carcinomas (PTC) in renal allograft recipients. In the present study we examined the incidence and biological behavior of PTCs among 1739 patients transplanted between January 1986 and December 1999 who had been followed for a mean period of 137 months (range, 84-238 months). During the follow-up, 129 (7.4%) recipients were identified to display posttransplantation malignancies, including 12 (0.7%) with PTCs. The 6 male and 6 female patients had a mean age of 41 years (range, 23-57 years). Nine cases (incidentalomas) were diagnosed based on ultrasonographic (US) screening. Eight of those 9 were TNM stage I, 2 of the 3 clinical carcinomas were TNM stage IVa. During a mean follow-up of 94 months (range, 18-159 months), 2 (16.7%) PTC patients developed locoregional recurrence, but no patients showed distant metastases. These data showed that recipients had a higher incidence of PTC compared with the general Korean population (0.7% vs 0.02%). Posttransplantation PTC tended to show no difference in gender distribution, and was often associated with aggressive lymphatic metastasis. However, most incidentalomas showed favorable treatment outcomes. In conclusion, routine surveillance of the thyroid gland using US screening is recommended to ensure early detection, treatment, and favorable prognosis of PTC.


Subject(s)
Carcinoma, Papillary/epidemiology , Kidney Transplantation/adverse effects , Neoplasms/epidemiology , Thyroid Neoplasms/epidemiology , Adolescent , Adult , Aged , Carcinoma, Papillary/pathology , Child , Child, Preschool , Female , Humans , Incidence , Male , Middle Aged , Prevalence , Retrospective Studies , Thyroid Hormones/blood , Thyroid Neoplasms/pathology , Transplantation, Homologous/adverse effects , Young Adult
15.
Int J Gynecol Cancer ; 14(2): 322-32, 2004.
Article in English | MEDLINE | ID: mdl-15086733

ABSTRACT

To evaluate anti-tumor effects of recombinant adenovirus p53, time-course p53, E6 expression, and cell growth inhibition were investigated in vitro and in vivo using cervical cancer cell lines such as CaSki, SiHa, HeLa, HeLaS3, C33A, and HT3. The cell growth inhibition was studied via cell count assay, MTT assay and neutral red assay. After transfecting AdCMVp53 into SiHa cells-xenografted nude mice, the transduction efficiency and anti-tumor effect were investigated for a month. The results showed that adenoviral p53 expression induced significant growth suppression on the cancer cells, in which E6 transcript was strongly repressed, and that the expression of p53 and E6 were remarkably dependent on each cell type. The transduction efficiency was highly maintained in vivo as well as in vitro, and the size of tumor was remarkably decreased in comparison with AdCMVLacZ control. The results suggest that the adenovirus-mediated p53 gene transfection was done very effectively in vitro and in vivo experiment, and the cell growth was suppressed via p53-dependent apoptotic cell death, and that the anti-tumor effect could be related to E6 and p53 expression pattern.


Subject(s)
Adenoviruses, Human/genetics , Genetic Therapy/methods , Repressor Proteins , Tumor Suppressor Protein p53/genetics , Uterine Cervical Neoplasms/genetics , Uterine Cervical Neoplasms/therapy , Animals , Cell Division/genetics , Cell Line, Tumor , Female , HeLa Cells , Humans , Mice , Mice, Nude , Oncogene Proteins, Viral/biosynthesis , Oncogene Proteins, Viral/genetics , Reverse Transcriptase Polymerase Chain Reaction , Tumor Suppressor Protein p53/biosynthesis , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/virology , Xenograft Model Antitumor Assays
16.
Plant Physiol ; 127(3): 1256-65, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11706204

ABSTRACT

The aromas of fruits, vegetables, and flowers are mixtures of volatile metabolites, often present in parts per billion levels or less. We show here that tomato (Lycopersicon esculentum Mill.) plants transgenic for a heterologous Clarkia breweri S-linalool synthase (LIS) gene, under the control of the tomato late-ripening-specific E8 promoter, synthesize and accumulate S-linalool and 8-hydroxylinalool in ripening fruits. Apart from the difference in volatiles, no other phenotypic alterations were noted, including the levels of other terpenoids such as gamma- and alpha-tocopherols, lycopene, beta-carotene, and lutein. Our studies indicate that it is possible to enhance the levels of monoterpenes in ripening fruits by metabolic engineering.


Subject(s)
Hydro-Lyases/genetics , Monoterpenes , Solanum lycopersicum/metabolism , Terpenes/metabolism , Acyclic Monoterpenes , Carotenoids/metabolism , Food Technology , Fruit/chemistry , Fruit/genetics , Fruit/metabolism , Gas Chromatography-Mass Spectrometry , Genetic Engineering , Hydro-Lyases/metabolism , Lutein/metabolism , Lycopene , Solanum lycopersicum/chemistry , Solanum lycopersicum/genetics , Oils, Volatile , Phenotype , Plants, Genetically Modified , Terpenes/chemistry , Tocopherols/metabolism , beta Carotene/metabolism
17.
J Pharm Pharmacol ; 53(9): 1287-94, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11578112

ABSTRACT

Syringin was found to possess immunomodulatory activity by which it inhibited the in-vitro immunohaemolysis of antibody-coated sheep erythrocytes by guinea-pig serum through suppression of C3-convertase of the classical complement. In this study, we examined its in-vitro and in-vivo activity on tumour necrosis factor (TNF)-alpha and nitric oxide (NO) production, CD4+ T cell and CD8+ cytotoxic T cell (CTLL-2) proliferation, and croton oil-, arachidonic acid- and fluorescein-isothiocynate (FITC)-induced mouse ear oedema model. Syringin significantly inhibited both TNF-alpha production from lipopolysaccharide (LPS)-stimulated RAW264.7 cells and CD8+ T cell (CTLL-2) proliferation in a dose-dependent manner, whereas neither NO production nor CD4+ T cell proliferation were blocked even by high concentrations of syringin. In the invivo experiments, syringin also significantly suppressed FITC-induced ear oedema in mice but not the ear oedema induced by croton or arachidonic acid. These results suggest that syringin may be implicated as an immunomodulator having an anti-allergic effect rather than an anti-inflammatory effect. The anti-allergic effect of syringin seems to be due, in part, to inhibition of TNF-alpha production and cytotoxic T cell proliferation.


Subject(s)
Adjuvants, Immunologic/pharmacology , Glucosides/immunology , Glucosides/pharmacology , Phenylpropionates/immunology , Phenylpropionates/pharmacology , T-Lymphocytes, Cytotoxic/drug effects , Tumor Necrosis Factor-alpha/drug effects , Animals , Cell Culture Techniques , Cell Division/drug effects , Guinea Pigs , Immune System/drug effects , Male , Mice , Mice, Inbred BALB C , Mice, Inbred ICR , Sheep , Tumor Necrosis Factor-alpha/biosynthesis
18.
Plant Physiol ; 127(1): 14-22, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11553730

ABSTRACT

Brassinosteroids (BRs) play important roles throughout plant development. Although many genes have been identified that are involved in BR biosynthesis, genetic approaches in Arabidopsis have led to the identification of only one gene, BRI1, that encodes a membrane receptor for BRs. To expand our knowledge of the molecular mechanism(s) of plant steroid signaling, we analyzed many dwarf and semidwarf mutants collected from our previous genetic screens and identified a semidwarf mutant that showed little response to exogenous BR treatments. Genetic analysis of the bin2 (BR-INSENSITIVE 2) mutant indicated that the BR-insensitive dwarf phenotype was due to a semidominant mutation in the BIN2 gene that mapped to the middle of chromosome IV between the markers CH42 and AG. A direct screening for similar semidwarf mutants resulted in the identification of a second allele of the BIN2 gene. Despite some novel phenotypes observed with the bin2/+ mutants, the homozygous bin2 mutants were almost identical to the well-characterized bri1 mutants that are defective in BR perception. In addition to the BR-insensitive dwarf phenotype, bin2 mutants exhibited BR insensitivity when assayed for root growth inhibition and feedback inhibition of CPD gene expression. Furthermore, bin2 mutants displayed an abscisic acid-hypersensitive phenotype that is shared by the bri1 and BR-deficient mutants. A gene dosage experiment using triploid plants suggested that the bin2 phenotypes were likely caused by either neomorphic or hypermorphic gain-of-function mutations in the BIN2 gene. Thus, the two bin2 mutations define a novel genetic locus whose gene product might play a role in BR signaling.


Subject(s)
Arabidopsis Proteins , Arabidopsis/genetics , Genes, Plant , Phytosterols/metabolism , Arabidopsis/metabolism , Brassinosteroids , Cholestanols/metabolism , Chromosome Mapping , Crosses, Genetic , Cytochrome P-450 Enzyme System/genetics , Gene Expression Regulation, Plant , Genes, Dominant , Mutation , Phenotype , Plant Growth Regulators/metabolism , Plant Growth Regulators/pharmacology , Plant Roots/growth & development , Plant Shoots/growth & development , Signal Transduction , Steroid Hydroxylases/genetics , Steroids, Heterocyclic/metabolism
19.
J Med Primatol ; 30(3): 141-7, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11515669

ABSTRACT

Cynomolgus monkeys were divided into two groups in terms of the reactivity of their lymphocytes with the FN18 monoclonal antibody, which is directed to the CD3 of rhesus monkeys. It was shown that 24 (12.2%) out of 196 monkeys did not have lymphocytes that reacted with the FN18, although T cells from those animals responded well to mitogenic stimulation. We have determined the nucleotide sequences of the CD3delta, CD3gamma, and CD3epsilon chains and found that two amino acids of the CD3epsilon chain of the FN18 non-reactive monkeys were different when compared with the FN18 reactive monkeys. Our results indicated that the CD3epsilon molecule of cynomolgus monkeys is polymorphic at the epitope level, which is recognized by the FN18 monoclonal antibody.


Subject(s)
CD3 Complex/genetics , Macaca fascicularis/genetics , Polymorphism, Genetic , Animals , Antibodies, Monoclonal/genetics , Antibodies, Monoclonal/immunology , Base Sequence , Epitopes , Female , Male , Molecular Sequence Data , Signal Transduction
20.
Plant Physiol ; 125(2): 539-55, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11161012

ABSTRACT

Plants that contain high concentrations of the defense compounds of the phenylpropene class (eugenol, chavicol, and their derivatives) have been recognized since antiquity as important spices for human consumption (e.g. cloves) and have high economic value. Our understanding of the biosynthetic pathway that produces these compounds in the plant, however, has remained incomplete. Several lines of basil (Ocimum basilicum) produce volatile oils that contain essentially only one or two specific phenylpropene compounds. Like other members of the Lamiaceae, basil leaves possess on their surface two types of glandular trichomes, termed peltate and capitate glands. We demonstrate here that the volatile oil constituents eugenol and methylchavicol accumulate, respectively, in the peltate glands of basil lines SW (which produces essentially only eugenol) and EMX-1 (which produces essentially only methylchavicol). Assays for putative enzymes in the biosynthetic pathway leading to these phenylpropenes localized many of the corresponding enzyme activities almost exclusively to the peltate glands in leaves actively producing volatile oil. An analysis of an expressed sequence tag database from leaf peltate glands revealed that known genes for the phenylpropanoid pathway are expressed at very high levels in these structures, accounting for 13% of the total expressed sequence tags. An additional 14% of cDNAs encoded enzymes for the biosynthesis of S-adenosyl-methionine, an important substrate in the synthesis of many phenylpropenes. Thus, the peltate glands of basil appear to be highly specialized structures for the synthesis and storage of phenylpropenes, and serve as an excellent model system to study phenylpropene biosynthesis.


Subject(s)
Alkenes/metabolism , Ocimum basilicum/metabolism , Phenols/metabolism , Biotransformation , Ocimum basilicum/ultrastructure , Plant Leaves/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL